NIH-funded research NIH-funded research

ABCD-USA Consortium: Data Analysis, Informatics and Resource Center

Funded at J. Craig Venter Institute, INC. · NIH-11613075 · Data updated 2026-11-12

A large U.S. effort to collect and harmonize brain imaging, biospecimens, and survey data from thousands of 9- to 10-year-olds over time to better understand brain development and health.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionJ. Craig Venter Institute, INC.
NIH-funded
Lab location1 site (San Diego, United States)
Project startAugust 8, 2026
Project endMarch 31, 2027
Funding year2026
Award (this year)$4,456,021
NIH project number3U24DA041123-12S1
Project IDNIH-11613075 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are 9- to 10-year-olds who are willing to participate with parental involvement across multiple research sites.

Less likely to help

Children who cannot participate due to safety concerns or consent limitations may not benefit from the data resources.

What this research studies

This project provides a centralized data and informatics platform for a national network of research sites studying young people's brain development, health, and environment. It uses standardized imaging, biospecimens, and digital data collection, with a strong focus on quality control and participant retention. Researchers and clinicians could access harmonized data and resources to study how early-life factors relate to later health outcomes in youth.

Why it matters

Potential benefit: If successful, it could accelerate understanding of childhood brain development and its links to health and behavior, informing prevention and early intervention.

How similar studies have gone: Large-scale pediatric brain development projects have produced valuable insights; ABCD aims to expand and harmonize these data.

Where this research is happening

  • J. Craig Venter Institute, INC.
    San Diego, United States
    Active

Researchers

  • Principal investigator: Dale, Anders M — J. Craig Venter Institute, INC.
  • Study coordinator: Dale, Anders M

Related research

Other NIH-funded projects on the same topics.

  • Prevention and Intervention Epicenter for CK20-004

    A translational effort from the J. Craig Venter Institute and Cleveland VA to develop and test prevention and intervention strategies for a specific health issue over several years.

    NIH research J. Craig Venter Institute, INC. · San Diego, United States · NIH-11549952

  • Lead bacteriophage therapy for tough Klebsiella infections

    Researchers are refining a five-phage mix to treat antibiotic-resistant Klebsiella pneumoniae infections and prepare it for a first-in-human trial.

    NIH research J. Craig Venter Institute, INC. · San Diego, United States · NIH-11384373

  • AI-powered signatures to predict flu severity in diverse patients

    Aging adults and children with flu may get sicker or recover differently, and this project will use artificial intelligence to find patterns across many data types to predict who will have severe illness.

    NIH research J. Craig Venter Institute, INC. · San Diego, United States · NIH-11377192

  • Engineering a virus-based therapy to fight Burkholderia infections

    A scientist team is editing a bacteriophage from Burkholderia to make it a safer, broader-use therapy for people with cystic fibrosis who have Burkholderia infections.

    NIH research J. Craig Venter Institute, INC. · San Diego, United States · NIH-11374693

  • ABCD USA data and resource center for adolescent brain and health

    Collects and shares detailed brain, health, and behavior data from nearly 12,000 U.S. children and teens to help researchers understand adolescent development.

    NIH research J. Craig Venter Institute, INC. · La Jolla, United States · NIH-11304523

  • Investigating a potential treatment target for acute myeloid leukemia

    This study is looking at how a specific protein called JMJD1C affects acute myeloid leukemia (AML) and whether combining treatments that target this protein with drugs that block the RAS pathway can help improve outcomes for patients, especially those with RAS mutations.

    NIH research J. Craig Venter Institute, INC. · La Jolla, United States · NIH-11176820

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.